|
Terumo received the following information: it was reported that a patient was presented on (b)(6) 2026 for a second dose of yeztugo.The medication was administered in the clinic without complications.On (b)(6) 2026, the patient contacted the healthcare provider and reported swelling, redness, pain, and purulent drainage ("pus") at the left abdominal injection site.The patient was referred to urgent care and was diagnosed with cellulitis and treated with antibiotics.Following antibiotic treatment, the patient's symptoms improved.
|